Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Frantz

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
Frontiers in Cardiovascular Medicine|January 26, 2024
Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathyVidhu Anand, Megan K Covington, Ushasi Saraswati, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 20, 2011
B-type natriuretic peptide levels and continuous-flow left ventricular assist devicesBasar Sareyyupoglu, Barry A Boilson, Lucian A Durham, et al.
The European Respiratory Journal|July 10, 2025
Attenuated Benefit to Vasodilators in Pulmonary Arterial Hypertension with high HFpEF probabilityYogesh N V Reddy, Robert P Frantz, Hilary M Dubrock, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 1, 2009
Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantationEugenia Raichlin, Brooks S Edwards, Walter K Kremers, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
The American Journal of Cardiology|October 30, 2012
Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertensionEvan L Hardegree, Arun Sachdev, Hector R Villarraga, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
Pulmonary Circulation|February 12, 2024
Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung diseaseMorgan E Bailey, Louise Durst, Hector R Cajigas, et al.
Transplantation|November 27, 2008
Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograftEugenia Raichlin, Krishnaswamy Chandrasekaran, Walter K Kremers, et al.
Journal of the American Heart Association|April 27, 2022
Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association RegistryKevin Y Chang, Sue Duval, David B Badesch, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Frontiers in Cardiovascular Medicine|January 26, 2024
Prevalence, sex differences, and implications of pulmonary hypertension in patients with apical hypertrophic cardiomyopathyVidhu Anand, Megan K Covington, Ushasi Saraswati, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 20, 2011
B-type natriuretic peptide levels and continuous-flow left ventricular assist devicesBasar Sareyyupoglu, Barry A Boilson, Lucian A Durham, et al.
The European Respiratory Journal|July 10, 2025
Attenuated Benefit to Vasodilators in Pulmonary Arterial Hypertension with high HFpEF probabilityYogesh N V Reddy, Robert P Frantz, Hilary M Dubrock, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 1, 2009
Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantationEugenia Raichlin, Brooks S Edwards, Walter K Kremers, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 28, 2017
Impact of declining renal function on outcomes in pulmonary arterial hypertension: A REVEAL registry analysisMurali M Chakinala, Daniel W Coyne, Raymond L Benza, et al.
The American Journal of Cardiology|October 30, 2012
Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertensionEvan L Hardegree, Arun Sachdev, Hector R Villarraga, et al.
Chest|February 18, 2019
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment StrategiesRaymond L Benza, Mardi Gomberg-Maitland, C Greg Elliott, et al.
Pulmonary Circulation|February 12, 2024
Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung diseaseMorgan E Bailey, Louise Durst, Hector R Cajigas, et al.
Transplantation|November 27, 2008
Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograftEugenia Raichlin, Krishnaswamy Chandrasekaran, Walter K Kremers, et al.
Journal of the American Heart Association|April 27, 2022
Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association RegistryKevin Y Chang, Sue Duval, David B Badesch, et al.
Pageof 25